CCLDCCLDHealthcare · Health Information Services

CCLD Stock Forecast: CareCloud, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$2.59
+5.71% on the day

The 3 Wall Street analysts covering CareCloud, Inc. hold a median 12-month price target of $7 — +170.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 71 of 100 as at 13 Aug 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$104.1M
Ticker Nerd rank
71 / 100
Median analyst target
$7.00
Analysts covering
3
Total return, dividends reinvested
1W
−1.5%
1M
+11.6%
YTD
−11.3%
1Y
+1.2%
From 52W high
−32.6%
From 52W low
+24.5%
$2.08
$3.84
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CCLD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores CareCloud, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
71 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
97
Quality
97
Size
75
Accruals
67
Growth
50
Revisions
50
Volatility
42
Momentum
41
Issuance
12

Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Issuance (12): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CCLD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CCLD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$3.00$4.00$5.00$6.00$7.00$8.00Oct 25Jan 26Apr 26Jul 26CCLDHigh $8.00Median $7.00Low $2.50

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
2 Buy1 Hold0 Sell
Low $2.50Median $7.00High $8.00

The green dot is the last close — the median target sits +170.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 Mar 2025Roth MKMReiteratesNeutral$3.50$1.50
15 Nov 2024BenchmarkReiteratesBuy
27 Aug 2024BenchmarkMaintainsBuy$4.00$4.50
16 May 2024BenchmarkMaintainsBuy
25 Mar 2024BenchmarkReiteratesBuy
22 Mar 2024Maxim GroupUpgradeBuy
16 Nov 2023BenchmarkReiteratesBuy
4 Aug 2023Roth MKMDowngradeNeutral
5 May 2023EF HuttonReiteratesBuy
20 Mar 2023EF HuttonInitiatesBuy
3 Mar 2023HC Wainwright & Co.ReiteratesBuy
13 Dec 2022Maxim GroupMaintainsBuy
15 Mar 2022B. Riley SecuritiesMaintainsBuy
11 June 2021Cantor FitzgeraldInitiatesOverweight

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CCLD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CCLD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.9%
Analysts raising
1
Analysts cutting
1
Fundamentals

CareCloud, Inc. (CCLD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
35.0×

Cheaper than 23% of US stocks

Price / sales
0.8×

Cheaper than 74% of US stocks

Price / book
6.0×

Cheaper than 18% of US stocks

EV / EBITDA
9.6×

Cheaper than 40% of US stocks

Growth & margins
Revenue growth (YoY)
16.4%

Higher than 65% of US stocks

Earnings growth (YoY)
−61.3%

Higher than 8% of US stocks

Gross margin
45.2%

Higher than 57% of US stocks

Operating margin
5.7%

Higher than 57% of US stocks

Net margin
6.2%

Higher than 63% of US stocks

Returns & dividend
Return on equity
21.8%

Higher than 83% of US stocks

Return on assets
6.8%

Higher than 84% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CCLD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
CCLDCareCloud, Inc.$104.1M
71
DHDefinitive Healthcare Corp.$91.4M
82
HCATHealth Catalyst, Inc.$131.7M
52
DRIODarioHealth Corp.$71.8M
43
OPRXOptimizeRx Corp.$163.0M
83
LFMDLifeMD, Inc.$166.6M
30
AMWLAmerican Well Corp.$214.2M
80

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own CareCloud, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CCLD news & analysis

CareCloud, Inc. (CCLD) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

Seeking Alpha published the transcript of CareCloud, Inc.'s (CCLD) Q2 2026 earnings call. The excerpt contains only the headline and source, with no additional detail from the call itself.

Why it matters — A CCLD watcher would care that the company's Q2 2026 earnings-call transcript is now available for review.

CareCloud Q2 Earnings Call Highlights

MarketBeat · 6 Aug 2026positive

CareCloud reported 16% second-quarter revenue growth and its ninth consecutive quarter of GAAP profitability. The company also highlighted investments in artificial intelligence, acquisition integration, and an expanded healthcare compliance offering during its Q2 earnings call.

Why it matters — A CCLD watcher would care because the results show sustained revenue growth and profitability alongside strategic investments in AI, acquisitions, and compliance that may shape the company's future direction.

CareCloud, Inc. (CCLD) Lags Q2 Earnings and Revenue Estimates

Zacks Investment Research · 6 Aug 2026negative

CareCloud, Inc. reported Q2 earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07 per share and falling short of the $0.07 per share it earned a year ago. The company also lagged revenue expectations for the quarter.

Why it matters — A CCLD watcher would care because the company failed to meet both earnings and revenue estimates, marking a decline from the prior-year quarter.

CareCloud Reports Second Quarter 2026 Results

GlobeNewsWire · 6 Aug 2026positive

CareCloud reported its financial results for the quarter ended June 30, 2026, with revenue growing 16% and marking its ninth consecutive quarter of positive GAAP net income. The company also reaffirmed its full-year guidance.

Why it matters — The results show continued revenue growth and sustained profitability, and the reaffirmed full-year guidance provides CCLD watchers with updated visibility into the company's financial trajectory.

CareCloud begins to notify hundreds of thousands after hackers stole medical records

TechCrunch · 30 July 2026negative

CareCloud is notifying hundreds of thousands of individuals that their medical records were stolen in a cyberattack earlier this year, with new details about the data breach emerging.

Why it matters — This security incident exposes CareCloud to potential regulatory penalties, litigation, and reputational damage that could impact its business relationships with healthcare clients.

FAQ

Frequently asked questions about CCLD stock

What is the CCLD stock price forecast for 2026-2027?

The 3 Wall Street analysts covering CareCloud, Inc. have a median 12-month price target of $7, with estimates ranging from $2.5 to $8. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CCLD stock a buy right now?

Of the 3 analysts covering CareCloud, Inc., 2 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks CareCloud, Inc. 71 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CCLD?

As at 13 Aug 2026, CareCloud, Inc. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).

Will CCLD stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +170.3% from the last close, and Ticker Nerd's factor model ranks CareCloud, Inc. 71 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CCLD stock forecast for 2030?

No analyst covering CareCloud, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CCLD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2.5 to $8 over the next 12 months.

How has CCLD stock performed over the past year?

CareCloud, Inc. returned +1.2% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does CareCloud, Inc. do?

CareCloud Inc. is a healthcare information technology company providing cloud-based and AI-powered solutions to medical practices, hospitals, and health systems across the United States.

What is the latest news on CCLD?

The most recent item we track (Seeking Alpha, 6 Aug 2026): "CareCloud, Inc. (CCLD) Q2 2026 Earnings Call Transcript". Seeking Alpha published the transcript of CareCloud, Inc.'s (CCLD) Q2 2026 earnings call. The excerpt contains only the headline and source, with no additional detail from the call itself.

Company

About CareCloud, Inc.

CareCloud Inc. is a healthcare information technology company providing cloud-based and AI-powered solutions to medical practices, hospitals, and health systems across the United States. It offers a comprehensive suite of proprietary software and services, including electronic health records (EHR), revenue cycle management (RCM), practice management (PM), patient experience management (PXM), business intelligence, telehealth, chronic care management, remote patient monitoring, robotic process automation, and digital health tools. CareCloud Inc. supports over 40,000 providers in more than 70 medical specialties and all 50 states, helping optimize clinical workflows, financial performance, administrative operations, and patient engagement. Notable offerings include AI-driven EHR solutions for specialties like dermatology, the Wellsoft emergency department information system for urgent care and inpatient settings, and tools for medical coding, provider credentialing, interoperability, group purchasing, and medical document indexing. Founded in 1999 and headquartered in Somerset, New Jersey, CareCloud Inc. serves as a key partner in modernizing healthcare delivery through integrated technology-enabled services that enhance efficiency and care quality.

CEO Mr. A. Hadi Chaudhry · 3,650 employees · United States · https://www.carecloud.com